These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1496552)

  • 1. Modification of rat skin allograft rejection by inhibition of thromboxane synthesis.
    Ruiz P; Woodson C; Rey L
    Transplantation; 1992 Aug; 54(2):385-8. PubMed ID: 1496552
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effect of CGS 13080, a thromboxane synthase inhibitor, in suppressing serum and urine immunoreactive thromboxane B2 in kidney transplant patients.
    Foegh ML; Lim K; Douglas F; Turk J; Helfrich GB; Taher SA; Alijani MR
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):424-7. PubMed ID: 3279631
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of the thromboxane synthesis inhibitor CGS-12970 on experimental acute renal allograft rejection.
    Mangino MJ; Brunt EM; Von Doersten P; Anderson CB
    J Pharmacol Exp Ther; 1989 Jan; 248(1):23-8. PubMed ID: 2643702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis of thromboxanes.
    Hammarström S; Diczfalusy U
    Adv Prostaglandin Thromboxane Res; 1980; 6():267-74. PubMed ID: 6770598
    [No Abstract]   [Full Text] [Related]  

  • 5. The inhibition of thromboxane synthesis has no influence on HgCl2-induced acute renal failure in the rat.
    Vanholder R; Laekeman G; Herman A; Saragananda B; Waterloos MA; Kesteloot D; Lámeire N
    Nephrol Dial Transplant; 1989; 4(7):625-31. PubMed ID: 2510059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
    Remuzzi G; Imberti L; Rossini M; Morelli C; Carminati C; Cattaneo GM; Bertani T
    J Clin Invest; 1985 Jan; 75(1):94-101. PubMed ID: 4038407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of kidney and skin graft rejection in rats by leflunomide, a new immunomodulating agent.
    Küchle CC; Thoenes GH; Langer KH; Schorlemmer HU; Bartlett RR; Schleyerbach R
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1083-6. PubMed ID: 1989154
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
    J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor pretreatment with IFN-gamma enhances MHC class II antigen expression and accelerates graft rejection by modified recipients.
    Ijzermans JN; Bouwman E; Jeekel J; Marquet RL
    Transplant Proc; 1990 Aug; 22(4):1941-2. PubMed ID: 2117821
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective thromboxane synthase inhibition does not increase in vivo synthesis of prostacyclin in healthy humans.
    Vesterqvist O; Gréen K; Henriksson P; Rasmanis G; Edhag O
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():165-8. PubMed ID: 1825536
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental model of chronic renal allograft rejection in rats and therapeutic efficacy of a new selective thromboxane A2 (TXA2) synthetase inhibitor (CV-4151).
    Tanabe K; Toma H; Sagara R; Takahashi K; Teraoka S; Ota K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):293-5. PubMed ID: 2650124
    [No Abstract]   [Full Text] [Related]  

  • 12. [Suppression of platelet aggregation as a result of two-component inhibition of a polyenzyme system of thromboxane synthesis].
    Varfolomeev SD; Lakin KM; Mevkh AT; Novikova NV; Rukazenkov IuZ
    Dokl Akad Nauk SSSR; 1985; 282(1):194-6. PubMed ID: 3928305
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppression of specific allograft reactivity of normal rat lymphocytes by treatment in vitro with serum from liver-grafted rats.
    Shinomiya T; Kamada N
    Transplant Proc; 1987 Feb; 19(1 Pt 1):558-9. PubMed ID: 3274819
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversible inhibition of thromboxane A2 production by imidazole 2-hydroxybenzoate (ITF 182) in the arachidonic acid injected rat. A comparison with acetylsalicylic acid and indometacin.
    Pagella PG; Agozzino S; Bellavite O; Donà GC
    Arzneimittelforschung; 1984; 34(5):597-8. PubMed ID: 6432000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway.
    Tobias LD; Hamilton JG
    Adv Prostaglandin Thromboxane Res; 1980; 6():453-6. PubMed ID: 6770605
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of thromboxane formation prevents endotoxin-induced renal fibrin deposition in jaundiced rats.
    Westwick J; Fletcher MS; Kakkar VV
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():83-91. PubMed ID: 6221642
    [No Abstract]   [Full Text] [Related]  

  • 17. Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression.
    Hara Y; Matsuura T; Imanishi M; Tahara H; Kurita T
    Transplant Proc; 1994 Dec; 26(6):3226-8. PubMed ID: 7527955
    [No Abstract]   [Full Text] [Related]  

  • 18. Thromboxane modulating agents. 3. 1H-imidazol-1-ylalkyl- and 3-pyridinylalkyl-substituted 3-[2-[(arylsulfonyl)amino]ethyl]benzenepropanoic acid derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists.
    Dickinson RP; Dack KN; Long CJ; Steele J
    J Med Chem; 1997 Oct; 40(21):3442-52. PubMed ID: 9341919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of first and second-set skin allografts in mice and rats under the influence of cysteine.
    Ryzewski J; Kossakowska M
    Arch Immunol Ther Exp (Warsz); 1974; 22(5):625-8. PubMed ID: 4614758
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of ICAM-1 and LFA-1 in cardiac allograft rejection of the rat.
    Komori A; Nagata M; Ochiai T; Nakajima K; Hori S; Asano T; Isono K; Tamatani T; Miyasaka M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):831-2. PubMed ID: 8094916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.